94319-80-9

Upstream product

• 57260-73-8 N-BOC-1,2-diaminoethane 
• 7335-27-5 ethyl 4-chlorobenzoate 
• 74-11-3 para-chlorobenzoic acid 
• 122-01-0 4-chloro-benzoyl chloride 

Downstream Products

• 1449798-41-7 C₄₇H₆₇ClN₄O₆ 
• 1449798-42-8 C₅₇H₈₃ClN₄O₉ 
• 1449798-43-9 C₅₇H₈₃ClN₄O₉ 
• 1449798-44-0 C₄₆H₆₅ClN₄O₆ 
• 1449798-45-1 C₄₈H₆₉ClN₄O₆ 
• 1449796-62-6 C₄₆H₆₅ClN₄O₅ 
• 1449797-62-9 C₁₄H₁₉ClN₂O₂S 
• 94319-79-6 N-(2-amino-ethyl)-4-chlorobenzamide hydrochloride 

Relevant academic research and scientific papers

NOVEL ARGINASE INHIBITORS

The present invention relates to novel arginase inhibitors of formula (I). These novel compounds are useful in the treatment of diseases that are associated with arginase activity, such as asthma, allergic rhinitis and COPD (chronic obstructive pulmonary disease).

LUPANE TRITERPENOID DERIVATIVES AND PHARMACEUTICAL USE THEREOF

The present invention relates to a lupane triterpenoid derivatives and pharmaceutical use thereof, specifically relates to a lupane triterpenoid derivatives of formula (I)?(III), a pharmaceutical composition and a combination preparation comprising a lupane triterpenoid derivatives or a pharmaceutically acceptable salt thereof in a therapeutically-effective dose, particularly relates to the use in preparation of a medicament for the treatment of HIV-1/AIDS.

BENZAMIDE DERIVATIVES

Benzamides of the formula I wherein R1 and R2 each independently is hydrogen, halogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, sulfamoyl, mono(lower alkyl)sulfamoyl or di(lower alkyl)sulfamoyl or R1 and R2 on adjacent carbon atoms together are